Christchurch Hospital is the largest tertiary hospital in the South Island of New Zealand. The public hospital is in the centre of Christchurch city, on the edge of Hagley Park, and serves the wider Canterbury region. The Canterbury District Health Board operates the hospital with funding from the government.

During the past decade, Christchurch Hospital conducted 134 clinical trials. In the 10-year time frame, 134 clinical trials started and 96 clinical trials were completed, i.e. on average, 71.6% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 52 clinical trials were completed. i.e. 115.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Christchurch Hospital" #1 sponsor was "Children's Oncology Group" with 42 trials, followed by "National Cancer Institute (NCI)" with 15 trials sponsored, "Boston Scientific Corporation" with 11 trials sponsored, "Gilead Sciences" with 11 trials sponsored and "Trans Tasman Radiation Oncology Group" with 11 trials sponsored. Other sponsors include 175 different institutions and companies that sponsored additional 106 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Christchurch Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 42 trials as a collaborator, "National Health and Medical Research Council, Australia" with 19 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 6 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 5 trials as a collaborator and "Bristol-Myers Squibb" with 5 trials as a collaborator. Other collaborators include 204 different institutions and companies that were collaborators in the rest 170 trials.

According to Clinical.Site data, the most researched conditions in "Christchurch Hospital" are "Coronary Artery Disease" (18 trials), "Ulcerative Colitis" (9 trials), "Acute Lymphoblastic Leukemia" (6 trials), "Crohn's Disease" (6 trials) and "Coronary Disease" (5 trials). Many other conditions were trialed in "Christchurch Hospital" in a lesser frequency.

Most popular intervention types in "Christchurch Hospital" are "Drug" (181 trials), "Other" (57 trials), "Radiation" (41 trials), "Device" (40 trials) and "Biological" (38 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "Laboratory Biomarker Analysis" (25 trials), "Cyclophosphamide" (24 trials), "Etoposide" (18 trials) and "Vincristine Sulfate" (18 trials). Other intervention names were less common.

The vast majority of trials in "Christchurch Hospital" are 253 trials for "All" genders, 10 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Christchurch Hospital". undefined are not yet recruiting, 45 are recruiting, 52 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 137 completed trials in Christchurch Hospital, 1 suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Christchurch Hospital, 12 "Phase 1" clinical trials were conducted, 58 "Phase 2" clinical trials and 136 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 46 trials that are defined as “Not Applicable".